Francis Flanagan

Title: The Innovations of Francis Flanagan

Introduction

Francis Flanagan is a notable inventor based in Conshohocken, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage formulations. His work has led to advancements that benefit patients and healthcare providers alike.

Latest Patents

Flanagan holds a patent for "Solid dosage formulations of an orexin receptor antagonist." This invention is directed to a pharmaceutical composition that includes the compound suvorexant, or a pharmaceutically acceptable salt thereof, combined with a concentration-enhancing polymer and optionally a pharmaceutically acceptable surfactant. This innovative formulation aims to improve the efficacy and delivery of the medication.

Career Highlights

Flanagan is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck has allowed him to work on cutting-edge pharmaceutical research and development. His expertise in formulation science has been instrumental in creating effective therapeutic solutions.

Collaborations

Throughout his career, Flanagan has collaborated with esteemed colleagues such as Paul A Harmon and Narayan Variankaval. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their projects.

Conclusion

Francis Flanagan's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His patent for solid dosage formulations showcases his commitment to improving patient care through scientific advancements.